Drug delivery devices market seen reaching $128.94 billion by 2030

The global drug delivery devices market is projected to grow from $102.15 billion in 2026 to $128.94 billion by 2030, reflecting steady demand for injectable therapies, home-based care and connected health tools. North America remained the largest regional market in 2025 as healthcare spending and adoption of advanced delivery systems continued to rise.

Why it matters: - Drug delivery devices are becoming more central to how medications are administered across hospitals, clinics and home care. - The market’s projected growth signals rising demand for devices that improve treatment precision, convenience and patient adherence. - Healthcare systems are also investing more in technologies that support chronic disease care, biologics and digital health integration.

What happened: - The Business Research Company said the global drug delivery devices market is projected to rise from $95.99 billion in 2025 to $102.15 billion in 2026. - That implies 6.4% annual growth in 2026. - The market is expected to reach $128.94 billion by 2030, at a 6.0% CAGR. - The report was released Aug. 5, 2026, and covers market size, trends and forecasts for 2026-2035. - The company also published a free sample and the full report online: Download the sample report and View the full report.

The details: - Drug delivery devices are designed to administer medications to targeted areas within the body. - These devices are used in hospitals, diagnostic centers, clinics and home care settings. - Growth in 2025 and 2026 has been supported by higher rates of chronic illness, wider use of injectable therapies, more drug administration in hospitals and greater reliance on infusion devices. - Improvements in pharmaceutical formulations have also supported demand. - The report says future growth will be driven by home-based drug delivery systems, investment in personalized medicine, expansion of biologics and biosimilars, connected delivery technologies and digital health platforms. - Emerging trends include smart drug delivery devices, self-administration injection tools, controlled release technologies, wearable delivery systems and patient-centric device design. - North America was the largest regional market in 2025. - Asia-Pacific ranked second in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Rising healthcare spending is helping create room for adoption of more advanced delivery devices. - In the UK, healthcare expenditure reached about $379 billion (£292 billion) in 2023, up 5.6% nominally from 2022, according to the Office for National Statistics. - That compares with 0.9% growth in 2022, suggesting stronger funding momentum for healthcare innovation. - The market’s shift toward home use and connected tools points to a broader move away from hospital-only care. - The emphasis on biologics, biosimilars and personalized medicine suggests drug delivery is increasingly tied to complex therapies that need more precise administration.

What's next: - The market is expected to keep expanding through 2030 as home-based care and digital health adoption increase. - Drug delivery device makers are likely to focus on wearables, smart systems and self-administration formats. - The company’s 2026 reports will include deeper market intelligence, TAM analysis, company scoring matrices, forecasting dashboards and updated graphics.

The bottom line: - Drug delivery devices remain a steady-growth healthcare segment, with demand anchored by chronic disease treatment, home care and smarter delivery technologies.